NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 21 filers reported holding NABRIVA THERAPEUTICS AG in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,192,000 | +97.0% | 99,390 | -2.3% | 0.00% | +100.0% |
| Q4 2016 | $605,000 | -16.6% | 101,740 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $725,000 | -9.3% | 101,740 | -4.5% | 0.00% | -33.3% |
| Q2 2016 | $799,000 | -27.8% | 106,540 | -13.7% | 0.00% | -25.0% |
| Q1 2016 | $1,106,000 | -6.2% | 123,440 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,179,000 | +21.7% | 123,440 | +21.0% | 0.00% | 0.0% |
| Q3 2015 | $969,000 | – | 102,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|